HCL Tech Ratings | Buy — Rising capex has been a drag on return ratios

By: |
Published: December 30, 2019 3:02:38 AM

FY15-19 was utilised for capex (Rs 118.7 bn; mainly for acquisitions of IPRs) and business takeovers (Rs 72.5 bn), leading to high intangibles (Rs 85.3 bn, 20.6% of NW) and goodwill (Rs 90.6 bn, 21.9% of NW).

HCL’s estimate of useful life for amortisation of IPRs (over 5-15 years) was higher than peers TCS (2-5 years) and IBM (over 1-5/7 years).

HCL’s FY19 annual report highlighted a continued focus on inorganic growth to expand the product portfolio. This resulted in higher capital intensity and thus a reduction in the return ratios (RoCE down 750bp to 24.8% over FY15-19). Around 54% of operating cash flow (Rs 356.6 bn) over

FY15-19 was utilised for capex (Rs 118.7 bn; mainly for acquisitions of IPRs) and business takeovers (Rs 72.5 bn), leading to high intangibles (Rs 85.3 bn, 20.6% of NW) and goodwill (Rs 90.6 bn, 21.9% of NW).

HCL’s estimate of useful life for amortisation of IPRs (over 5-15 years) was higher than peers TCS (2-5 years) and IBM (over 1-5/7 years). While Ebitda was up 23.8% to Rs 139.3 bn in FY19, its conversion to cash flows declined to 83% (FY18: 95%) as the cash conversion cycle elongated from 64 days in FY18 to 68 days in FY19. This was primarily due to a decline in advance from customers to 1 day (FY18: 5 days). A comparison of HCL with peers suggests that it has generated a higher RoE (26.0%) than Infosys (23.7%) and Wipro (17.2%) but lower than TCS (36.0%).

Rising capital intensity drags return ratios: Over FY15-19, HCL utilised 54% of OCF (Rs 356.6 bn) for capex and business takeovers. Of the cumulative capex over FY15-19, ~Rs 87.5 bn was used for the acquisition of licensed IPRs from IBM. Note that the CAGR in capital employed (17.3%) was higher than that in earnings (Ebit and other income; ~9.2%). As a result, RoCE declined 750bp to 24.8% (post tax) over FY15-19.

Significant intangibles with higher estimated useful life than peers: Licensed IPRs formed significant part of intangibles at ~86% (Rs 73.5 bn) in FY19. HCL’s amortisation period for licensed IPRs (over 5-15 years) is higher than that of peer companies, and thus amortisation of IPRs in line with peers could materially impact profitability (~3.9% to 63.3% of PBT in FY19), in our view. Goodwill arising from business acquisitions is not amortised but tested for impairment at the end of each year.

Operating performance improves: Ebitda increased by ~23.8% in FY19, supported by revenue growth of ~19.5% and Ebitda margin expansion of ~80bp to 23.0%. This is mainly due to higher contribution from the Ebitda margin-accretive licensed IP business, which led to lower personnel cost (-45bp to Rs 292.8 bn) and outsourcing cost (-85bp to Rs 97.6 bn). Depreciation & amortisation increased from Rs 13.8 bn (2.7% of revenue) in FY18 to
Rs 20.7 bn (3.4% of revenue) in FY19.

 

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Next Stories
1India Inc garners Rs 8.7 lakh crore from domestic and overseas markets in 2019
2From slumping growth to soaring valuations, Sensex remained stubbornly optimistic in 2019
3FPIs remain net buyers in December; invest over Rs 2,600 crore